RNU6-925P

Across TCGA pan-cancer cohorts, RNU6-925P RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated RNU6-925P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RNU6-925P RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RNU6-925P expression acts as an unfavorable survival marker, although some lineages such as BLCA and BRCA show a favorable association.

BLCA, BRCA, and COAD are the cancer types where RNU6-925P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Median	III,IV	0.499	0.229	<.001	83	view →
BRCA	OS	Tertile	All	0.974	0.931	.003	63	view →
COAD	DFS	Median	III,IV	0.585	0.741	.003	38	view →
GBM	DFS	Quartile	All	0.462	0.146	.001	28	view →
THCA	DFS	Quartile	II,III,IV	0.784	1.000	<.001	24	view →
ACC	DFS	Median	All	0.451	0.701	.010	16	view →
UCEC	OS	Tertile	All	0.834	0.900	.028	16	view →
LUSC	OS	Tertile	All	0.789	0.692	.006	14	view →
LUAD	OS	Median	IV	0.711	0.286	.019	12	view →
UVM	OS	Median	III,IV	0.296	1.000	.005	12	view →
LAML	DFS	Median	All	0.606	0.338	.005	10	view →
CHOL	OS	Median	All	0.863	0.404	.028	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

RNU6-925P–BLCA (DFS)

Open the BLCA breakdown →